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June Supplement 20106S Abstractspatients (24.4%) at some point during routine surveillance,
including, Type I (n  56, 23.0%), Type II (n  166,
68.3%), Type III (n  11, 4.5%), Type IV (n  2, 0.8%),
and Type V (n 8, 3.3%). One hundred and seven second-
ary interventions were performed in 85 patients (9.2%) for
EVAR related problems, and included placement of an iliac
extender (n  36, 33.7.%), proximal cuff placement (n 
20, 18.7%), embolization of a branch vessel (n  24,
22.4%), stent graft relining (n  15, 14.0%), ligation of a
branch vessel (n  4, 3.7%) fem-fem bypass grafts (n  3,
2.8%), ilio-femoral thrombectomy (n  3, 2.8%), and
hypogastric artery stent placement (n  2, 1.9%). Sixteen
endografts (1.7%) required explantation after primary fail-
ure (10) or failed secondary intervention (6). Indications
for explant included expanding size or persistent endoleak
(n  12), infection (n  2), and rupture (2). Three
instances of rupture following EVAR were noted.
Conclusions: Secondary aneurysm related procedures
after EVAR were required in10% of this population with
most requiring minimally invasive catheter based proce-
dures. Long-term surveillance remains important to pro-
vide optimal vascular outcomes for these patients.
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Objectives:To assess the accuracy of indirect estimated
radiation doses during endovascular thoracoabdominal an-
eurysm repair (eTAAA).
Methods: Patients undergoing eTAAA had imaging
system generated indirect radiation parameters recorded
concurrently with direct measurements of radiation expo-
sure patterns using radiochromatic film. Operator dose was
determined by electronic dosimeters. Observed radiation
exposure patterns were reproduced in phantoms allowing
for effective radiation dose calculations. Continuous vari-
ables were assessed with scatter plots and Pearson coeffi-
cients.
Results: No patients had evidence of radiation induced
skin injury. Cumulative air kerma (CAK) exceeded 15Gy in
3 patients, however, direct measurements were below
15Gy in all patients. Peak skin dose (PSD), quantified using
gafchromic film, correlated weakly with fluoroscopy time(FT) but better with CAK and kerma air product (KAP).
The formula“PSD 0.6770.257CAK”provides the best
estimate of actual PSD. The average effective dose was
119.68mSv (for type II or III eTAAA) and 76.46mSv (type
IV eTAAA). Mean operator effective dose was 0.17mSv/
case, and correlated best with KAP (r 0.82, p 0.0001).
Conclusions: FT, CAK and KAP represent poor mark-
ers of PSD, and directly measured PSD did not correlate
with clinical events. The effective radiation dose of eTAAA
is equivalent to 2 preoperative CT scans. An operator could
perform up to 294 eTAAA annually before reaching the
maximum recommended operator dose.












Indirect FT (min) 104.42 140.67 81.92 r 0.55 p 0.0001
Indirect CAK (Gy) 7.45 9.64 6.09 0.80 0.0001









Direct Procedure 87.3 112.3 71.8
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Objectives: Successful vein graft adaptation to the
arterial environment is critical to maintain long-term vas-
cular graft patency. However, the mechanism of vein graft
adaptation remains unclear. Since Eph-B4, an embryonic
determinant of venous identity, expression is reduced dur-
ing vein graft adaptation, we determined whether Eph-B4,
and the shear stress-sensing caveolin-1 (cav-1), play mech-
anistic roles to limit wall thickening during vein graft
adaptation.
Methods: Full length mouse Eph-B4 cDNA was in-
serted into the pShuttle-IRES-hrGFP2 vector and the
cav-1 binding domain (CBD) was mutated at w804. In-
trathoracic inferior vena cava was harvested from wild-type
(WT) or cav-1 knockout (cav-1-KO) mice and placed as an
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Eph-B4 was stimulated with Ephrin-B2/Fc injected IP
every other day until harvest; other vein grafts were locally
treated with WT or mutated Eph-B4 coding adenovirus
(1.0x109 pfu). Vein grafts were harvested and analyzed
after 3-4 weeks.
Results: Stimulation of Eph-B4 with Ephrin-B2/Fc
limited wall thickness (0.03  0.01 mm vs 0.06  0.01
mm, n  5-7). Eph-B4 colocalized with cav-1 in sucrose
gradient separation and co-immunoprecipitation. Vein
grafts derived from cav-1-KO mice had increased wall
thickness (0.09 0.01 mm vs 0.05 0.01 mm, n 3-5).
Unlike WT grafts, Ephrin-B2/Fc treated Cav-1 KO vein
grafts did not have reduced wall thickness (0.09  0.01
mm, n  4). CBD mutated Eph-B4 was unable to phos-
phorylate tyrosine in vitro; adenovirus incorporating the
CBD mutated Eph-B4 did not limit vein graft wall thick-
ness compared to reduced wall thickness with WT Eph-B4
adenovirus (0.09  0.01 mm vs 0.06  0.01 mm, n  6).
Conclusions: Eph-B4 is functional in adult veins and
actively limits vein graft wall thickening during adaptation
to the arterial environment. Caveolin-1 may act as the shear
stress sensor for Eph-B4, suggesting that the Eph-B4-
caveolin-1 pathway may be a therapeutic target to improve
vein graft patency.
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Objectives: To determine the cerebrovascular risk
stratification potential of degree of stenosis, clinical features
and ultrasonic plaque characteristics in patients with asymp-
tomatic internal carotid artery (ICA) stenosis.
Methods: In this prospective, multicentre, cohort
study, 1121 patients with 50-99% asymptomatic ICA ste-
nosis in relation to the bulb (ECST) undergoing medical
intervention were followed-up for 6-98 (mean 48) months.
Hazard ratios for ICA stenosis, clinical features and ultra-
sonic plaque texture features associated with ipsilateral
cerebrovascular or retinal ischemic (CORI) events werecalculated using univariate analysis and Cox proportional
hazard models.
Results: During follow-up, a total of 130 CORI events
including 59 strokes occurred. Severity of stenosis, smok-
ing history of more than 10 pack-years, systolic blood
pressure, history of contralateral TIA or stroke, low gray
scale median (GSM), increased plaque area, plaque types 1,
2 and 3, and presence of discrete white areas without
acoustic shadowing (DWA) were associated with increased
risk. The area under the curve in ROC curves for stenosis,
stenosis combined with clinical features and stenosis com-
bined with clinical features and plaque features was 0.59,
0.66 and 0.82 respectively. In a Cox proportional hazard
model, stenosis, history of contralateral TIA or stroke,
GSM, plaque area and DWA were independent predictors
of stroke. Of the 923 patients with 70 % stenosis ( 50%
NASCET) 5-year stroke rates less than 5%were predicted in
524, 5-9% in 149, 10-19% in 176, 20-29% in 40 and rates
equal or greater than 30% in 34 patients.
Conclusions: Cerebrovascular risk stratification is pos-
sible using a combination of clinical and ultrasonic plaque
features. These finding can be used to refine the indications
for carotid endarterectomy. However, they need to be
validated in additional prospective studies or the medical
arm of future randomized controlled trials of medical vs
surgical or endovascular therapy.
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Objectives: Increasing data are suggesting that statins
can significantly decrease cardiovascular and cerebrovascu-
lar events due to a plaque stabilization effect. However, the
benefit of statins in patients undergoing carotid angioplasty
and stenting (CAS) for carotid stenosis is not well defined.
Aim of this study was to investigate whether statins use was
associated with decreased perioperative and late risks of
stroke, mortality and restenosis in patients undergoing
CAS.
